Membrane processes for removal of pharmaceutically active compounds (PhACs) from water and wastewaters.
暂无分享,去创建一个
R Y Surampalli | M Verma | R. Surampalli | S. Brar | M. Verma | J. Valéro | M. Taheran | Satinder K Brar | Mehrdad Taheran | T C Zhang | J R Valero | T. C. Zhang | T. Zhang | T. C. Zhang | Tian C. Zhang
[1] Robert C Andrews,et al. The influence of natural organic matter and cations on the rejection of endocrine disrupting and pharmaceutically active compounds by nanofiltration. , 2009, Water research.
[2] Zhi‐Kang Xu,et al. Nanofibrous membranes containing reactive groups : Electrospinning from poly(acrylonitrile-co-maleic acid) for lipase immobilization , 2006 .
[3] L. Nghiem,et al. Removal of trace organic contaminants by an MBR comprising a mixed culture of bacteria and white-rot fungi. , 2013, Bioresource technology.
[4] F. Elazhar,et al. Techno-economic comparison of reverse osmosis and nanofiltration in desalination of a Moroccan brackish groundwater , 2015 .
[5] Marta Carballa,et al. How are pharmaceutical and personal care products (PPCPs) removed from urban wastewaters? , 2008 .
[6] In S. Kim,et al. Comparison of the removal efficiency of endocrine disrupting compounds in pilot scale sewage treatment processes. , 2008, Chemosphere.
[7] Sven-Uwe Geissen,et al. Elimination of carbamazepine in a non-sterile fungal bioreactor. , 2012, Bioresource technology.
[8] Jiangyong Hu,et al. Rejection of estrone by nanofiltration: Influence of solution chemistry , 2007 .
[9] A. Schäfer,et al. Removal of pharmaceuticals and endocrine disrupting compounds in a water recycling process using reverse osmosis systems , 2011 .
[10] M. Petrovíc. Analysis and removal of emerging contaminants in wastewater and drinking water , 2003 .
[11] Zhi‐Kang Xu,et al. Electrospun nanofibrous membranes filled with carbon nanotubes for redox enzyme immobilization , 2008 .
[12] Menachem Elimelech,et al. Impact of humic acid fouling on membrane performance and transport of pharmaceutically active compounds in forward osmosis. , 2013, Water Research.
[13] A. Schäffer,et al. Factors affecting the removal of organic micropollutants from wastewater in conventional treatment plants (CTP) and membrane bioreactors (MBR) , 2008 .
[14] Long D. Nghiem,et al. Rejection of pharmaceutically active compounds by forward osmosis: Role of solution pH and membrane orientation , 2012 .
[15] Allan R. Chivas,et al. Coupling effects of feed solution pH and ionic strength on the rejection of boron by NF/RO membranes , 2011 .
[16] J. Cravedi,et al. Removal of bisphenol A by a nanofiltration membrane in view of drinking water production. , 2006, Water research.
[17] L. Nghiem,et al. Removal of emerging trace organic contaminants by MBR-based hybrid treatment processes , 2013 .
[18] G. Amy,et al. Priority organic micropollutants in water sources in Flanders and the Netherlands and assessment of removal possibilities with nanofiltration. , 2007, Environmental pollution.
[19] Rijul Dhingra,et al. Forward Osmosis in India: Status and Comparison with Other Desalination Technologies , 2014, International scholarly research notices.
[20] G. Amy,et al. Rejection of pharmaceutically active compounds and endocrine disrupting compounds by clean and fouled nanofiltration membranes. , 2009, Water research.
[21] C. Jolivalt. Immobilization of laccase from Trametes versicolor on a modified PVDF microfiltration membrane: characterization of the grafted support and application in removing a phenylurea pesticide in wastewater , 2000 .
[22] D. Barceló,et al. Oxidation of atenolol, propranolol, carbamazepine and clofibric acid by a biological Fenton-like system mediated by the white-rot fungus Trametes versicolor. , 2010, Water research.
[23] Shane A. Snyder,et al. Removal of endocrine disrupting compounds and pharmaceuticals by nanofiltration and ultrafiltration membranes , 2007 .
[24] L. Nghiem,et al. Effects of membrane fouling on the nanofiltration of pharmaceutically active compounds (PhACs): Mechanisms and role of membrane pore size , 2007 .
[25] Lubertus Bijlsma,et al. Investigation of pharmaceuticals and illicit drugs in waters by liquid chromatography-high-resolution mass spectrometry , 2014 .
[26] A. Krastanov,et al. Biodegradation of phenols by laccase immobilised in a membrane reactor , 2000 .
[27] Menachem Elimelech,et al. Comparison of the removal of hydrophobic trace organic contaminants by forward osmosis and reverse osmosis. , 2012, Water research.
[28] G. Feijoo,et al. Laccase-catalyzed degradation of anti-inflammatories and estrogens , 2010 .
[29] Jaeweon Cho,et al. Evaluating controllability of pharmaceuticals and metabolites in biologically engineered processes, using corresponding octanol–water distribution coefficient , 2011 .
[30] Menachem Elimelech,et al. Pharmaceutical retention mechanisms by nanofiltration membranes. , 2005, Environmental science & technology.
[31] Zhi‐Kang Xu,et al. Covalent immobilization of lipase from Candida rugosa onto poly(acrylonitrile-co-2-hydroxyethyl methacrylate) electrospun fibrous membranes for potential bioreactor application. , 2008, Bioresource technology.
[32] Jixiao Wang,et al. Advanced treatment of a complex pharmaceutical wastewater by nanofiltration: Membrane foulant identification and cleaning , 2010 .
[33] Menachem Elimelech,et al. Energy requirements of ammonia-carbon dioxide forward osmosis desalination , 2007 .
[34] Sven-Uwe Geissen,et al. In vitro degradation of carbamazepine and diclofenac by crude lignin peroxidase. , 2010, Journal of hazardous materials.
[35] T. Urase,et al. Retention of a wide variety of organic pollutants by different nanofiltration/reverse osmosis membranes: controlling parameters of process , 2003 .
[36] Craig D. Adams,et al. Endocrine disrupting compounds removal from wastewater, a new challenge , 2006 .
[37] Xitao Liu,et al. Single-solute and bi-solute sorption of phenanthrene and dibutyl phthalate by plant- and manure-derived biochars. , 2014, The Science of the total environment.
[38] Y. Laor,et al. Using Dissolved Humic Acid To Remove Hydrophobic Contaminants from Water by Complexation−Flocculation Process , 1998 .
[39] Jeill Oh,et al. Adsorption of selected endocrine disrupting compounds and pharmaceuticals on activated biochars. , 2013, Journal of hazardous materials.
[40] K. Kimura,et al. Rejection of neutral endocrine disrupting compounds (EDCs) and pharmaceutical active compounds (PhACs) by RO membranes , 2004 .
[41] Jonghun Han,et al. Sonocatalytic-TiO2 nanotube, Fenton, and CCl4 reactions for enhanced oxidation, and their applications to acetaminophen and naproxen degradation , 2015 .
[42] D. Barceló,et al. Fate and removal of pharmaceuticals and illicit drugs in conventional and membrane bioreactor wastewater treatment plants and by riverbank filtration , 2009, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[43] F. Naeimpoor,et al. Effect of hydraulic retention time and temperature on submerged membrane bioreactor (SMBR) performance , 2012, Korean Journal of Chemical Engineering.
[44] Ignasi Rodríguez-Roda,et al. Comparison of removal of pharmaceuticals in MBR and activated sludge systems , 2010 .
[45] H. Okamura,et al. Elimination of carbamazepine by repeated treatment with laccase in the presence of 1-hydroxybenzotriazole. , 2010, Journal of hazardous materials.
[46] G. Amy,et al. A QSAR model for predicting rejection of emerging contaminants (pharmaceuticals, endocrine disruptors) by nanofiltration membranes. , 2010, Water research.
[47] T. Poerio,et al. Diclofenac Transport through Stagnant Sandwich and Supported Liquid Membrane Systems , 2006 .
[48] S. Chellam,et al. Simplified analysis of contaminant rejection during ground- and surface water nanofiltration under the information collection rule. , 2001, Water research.
[49] Sangho Lee,et al. A novel nanofiltration hybrid system to control organic micro-pollutants: application of dual functional adsorbent/catalyst , 2008 .
[50] Huaidong Zhou,et al. Sorption of phthalic acid esters in two kinds of landfill leachates by the carbonaceous sorbents. , 2013, Bioresource technology.
[51] Wenshan Guo,et al. The fate of pharmaceuticals, steroid hormones, phytoestrogens, UV-filters and pesticides during MBR treatment. , 2013, Bioresource technology.
[52] Jiti Zhou,et al. Factors affecting the membrane performance in submerged membrane bioreactors , 2006 .
[53] C. Guizard,et al. Mesoporous anatase coatings for coupling membrane separation and photocatalyzed reactions , 2005 .
[54] Shane A. Snyder,et al. Nanofiltration and ultrafiltration of endocrine disrupting compounds, pharmaceuticals and personal care products , 2006 .
[55] Heleen De Wever,et al. Comparison of sulfonated and other micropollutants removal in membrane bioreactor and conventional wastewater treatment. , 2007, Water research.
[56] Damià Barceló,et al. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. , 2009, Water research.
[57] Fenglin Yang,et al. Removal of trace antibiotics from wastewater: A systematic study of nanofiltration combined with ozone-based advanced oxidation processes , 2014 .
[58] Young-Mo Kim,et al. Enhanced transformation of triclosan by laccase in the presence of redox mediators. , 2010, Water research.
[59] C. Vandecasteele,et al. Influence of hydrophobicity on retention in nanofiltration of aqueous solutions containing organic compounds , 2005 .
[60] A. Vukovic,et al. Effect of water matrices on removal of veterinary pharmaceuticals by nanofiltration and reverse osmosis membranes. , 2011, Journal of environmental sciences.
[61] Corinne Cabassud,et al. Evaluation of membrane bioreactor on removal of pharmaceutical micropollutants: a review , 2015 .
[62] A. Zimmerman,et al. Adsorption of sulfamethoxazole on biochar and its impact on reclaimed water irrigation. , 2012, Journal of hazardous materials.
[63] Jörg E. Drewes,et al. Effects of membrane degradation on the removal of pharmaceutically active compounds (PhACs) by NF/RO filtration processes , 2009 .
[64] Joseph R. V. Flora,et al. Enhanced ultrasonic degradation of acetaminophen and naproxen in the presence of powdered activated carbon and biochar adsorbents , 2014 .
[65] A. Bes-Piá,et al. Reactive dyes rejection and textile effluent treatment study using ultrafiltration and nanofiltration processes , 2012 .
[66] T. Heberer,et al. Production of Drinking Water from Highly Contaminated Surface Waters: Removal of Organic, Inorganic, and Microbial Contaminants Applying Mobile Membrane Filtration Units , 2002 .
[67] F. Omil,et al. Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage , 2008 .
[68] S. Maeng,et al. Influences of solid retention time, nitrification and microbial activity on the attenuation of pharmaceuticals and estrogens in membrane bioreactors. , 2013, Water research.
[69] L. Nghiem,et al. Mechanisms underlying the effects of membrane fouling on the nanofiltration of trace organic contaminants , 2010 .
[70] Victor Yangali-Quintanilla,et al. Rejection of micropollutants by clean and fouled forward osmosis membrane. , 2011, Water research.
[71] H Kroiss,et al. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. , 2005, Water research.
[72] Z. H. Li,et al. Residual pharmaceutically active compounds (PhACs) in aquatic environment - status, toxicity and kinetics: a review. , 2018 .
[73] Jinguo Kang,et al. Removal of trace organic contaminants by a membrane bioreactor-granular activated carbon (MBR-GAC) system. , 2012, Bioresource technology.
[74] Y. Hsieh,et al. Immobilization of lipase enzyme in polyvinyl alcohol (PVA) nanofibrous membranes , 2008 .
[75] K. Kimura,et al. Adsorption of hydrophobic compounds onto NF/RO membranes: an artifact leading to overestimation of rejection , 2003 .
[76] J. V. Dijk,et al. Influence of membrane fouling by (pretreated) surface water on rejection of pharmaceutically active compounds (PhACs) by nanofiltration membranes , 2009 .
[77] W. Leukes,et al. Ultrafiltration of petrochemical industrial wastewater using immobilised manganese peroxidase and laccase: application in the defouling of polysulphone membranes☆ , 2002 .
[78] Ze-hua Liu,et al. Removal mechanisms for endocrine disrupting compounds (EDCs) in wastewater treatment - physical means, biodegradation, and chemical advanced oxidation: a review. , 2009, The Science of the total environment.
[79] Kyung-Duk Zoh,et al. Adsorption characteristics of selected hydrophilic and hydrophobic micropollutants in water using activated carbon. , 2014, Journal of hazardous materials.
[80] Jaya Kandasamy,et al. PHARMACEUTICAL WASTEWATER TREATMENT BY MEMBRANE BIOREACTOR PROCESS- A CASE STUDY IN SOUTHERN TAIWAN , 2008 .
[81] M. Mauter,et al. Emerging Pollutants – Part II: Treatment , 2012 .
[82] M. I. Pariente,et al. Coupling membrane separation and photocatalytic oxidation processes for the degradation of pharmaceutical pollutants. , 2013, Water research.
[83] R. Tyagi,et al. Removal of estrogenic activity of natural and synthetic hormones from a municipal wastewater: efficiency of horseradish peroxidase and laccase from Trametes versicolor. , 2008, Chemosphere.
[84] Xiaoyan Yuan,et al. Immobilization of cellulase in nanofibrous PVA membranes by electrospinning , 2005 .
[85] T. Heberer. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. , 2002, Toxicology letters.
[86] Adriano Joss,et al. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. , 2007, The Science of the total environment.
[87] M. Moeder,et al. Degradation of hydroxylated compounds using laccase and horseradish peroxidase immobilized on microporous polypropylene hollow fiber membranes , 2004 .
[88] O. Kusakabe,et al. Biodegradation characteristics of pharmaceutical substances by whole fungal culture Trametes versicolor and its laccase. , 2010 .
[89] T. Urase,et al. The effect of deterioration of nanofiltration membrane on retention of pharmaceuticals , 2007 .
[90] Chuyang Y. Tang,et al. Rejection of pharmaceuticals by forward osmosis membranes. , 2012, Journal of hazardous materials.
[91] M. Ashokkumar,et al. Combined advanced oxidation processes for the synergistic degradation of ibuprofen in aqueous environments. , 2010, Journal of hazardous materials.
[92] S. Geissen,et al. Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. , 2008, Chemosphere.
[93] M. Elimelech,et al. Role of electrostatic interactions in the retention of pharmaceutically active contaminants by a loose nanofiltration membrane , 2006 .
[94] Long D Nghiem,et al. Simultaneous activated carbon adsorption within a membrane bioreactor for an enhanced micropollutant removal. , 2011, Bioresource technology.
[95] S. Sahebdelfar,et al. Interaction effects in multicomponent separation by reverse osmosis , 2001 .
[96] Sang-June Choi,et al. The methods of identification, analysis, and removal of endocrine disrupting compounds (EDCs) in water. , 2009, Journal of hazardous materials.
[97] K. Kimura,et al. REJECTION OF ORGANIC MICROPOLLUTANTS (DISINFECTION BY-PRODUCTS, ENDOCRINE DISRUPTING COMPOUNDS, AND PHARMACEUTICALLY ACTIVE COMPOUNDS) BY NF/RO MEMBRANES , 2003 .
[98] Long D. Nghiem,et al. Removal of micropollutants by membrane bioreactor under temperature variation , 2011 .
[99] A. López,et al. Effective organics degradation from pharmaceutical wastewater by an integrated process including membrane bioreactor and ozonation. , 2010, Chemosphere.
[100] J. Müller,et al. Biodegradation of persistent polar pollutants in wastewater: comparison of an optimised lab-scale membrane bioreactor and activated sludge treatment. , 2006, Water research.
[101] K. Ro,et al. Sorption of bisphenol A, 17α-ethinyl estradiol and phenanthrene on thermally and hydrothermally produced biochars. , 2011, Bioresource technology.
[102] Shane A. Snyder,et al. Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals , 2007 .
[103] C. Purushothaman,et al. Pharmaceutically Active Compounds (PhACs): A Threat for AquaticEnvironment? , 2013 .
[104] L. Nghiem,et al. Effects of chemical cleaning on the nanofiltration of pharmaceutically active compounds (PhACs) , 2012 .
[105] Simon Judd,et al. The cost of a large-scale hollow fibre MBR. , 2010, Water research.
[106] D. Bagley,et al. The rejection of endocrine disrupting and pharmaceutically active compounds by NF and RO membranes as a function of compound and water matrix properties , 2008 .
[107] T. Vicent,et al. Ability of white-rot fungi to remove selected pharmaceuticals and identification of degradation products of ibuprofen by Trametes versicolor. , 2009, Chemosphere.
[108] Chung‐Hak Lee,et al. Surface modification of nanofiltration membranes to improve the removal of organic micro-pollutants (EDCs and PhACs) in drinking water treatment: Graft polymerization and cross-linking followed by functional group substitution , 2008 .
[109] Sangho Lee,et al. A novel hybrid system for the removal of endocrine disrupting chemicals: Nanofiltration and homogeneous catalytic oxidation , 2008 .
[110] Y. Hadar,et al. Transformation of the recalcitrant pharmaceutical compound carbamazepine by Pleurotus ostreatus: role of cytochrome P450 monooxygenase and manganese peroxidase. , 2011, Environmental science & technology.
[111] Long D. Nghiem,et al. NF/RO filtration of the hydrophobic ionogenic compound triclosan : Transport mechanisms and the influence of membrane fouling , 2008 .
[112] Helena Palmquist,et al. Nanofiltration for the separation of pharmaceuticals from nutrients in source-separated urine. , 2006, Water research.
[113] B. Bruggen,et al. Removal of micropollutants during drinking water production from surface water with nanofiltration , 2006 .
[114] Damia Barcelo,et al. Degradation of carbamazepine by Trametes versicolor in an air pulsed fluidized bed bioreactor and identification of intermediates. , 2012, Water research.
[115] Zhi‐Kang Xu,et al. Nanofibrous poly(acrylonitrile-co-maleic acid) membranes functionalized with gelatin and chitosan for lipase immobilization. , 2006, Biomaterials.
[116] F. Spina,et al. Endocrine Disrupting Chemicals (edcs) in Municipal Wastewaters: Effective Degradation and Detoxification by Fungal Laccases , 2013 .
[117] G. Esposito,et al. Coupling of membrane filtration and advanced oxidation processes for removal of pharmaceutical residues: A critical review , 2015 .
[118] Robert C. Andrews,et al. Membrane adsorption of endocrine disrupting compounds and pharmaceutically active compounds , 2007 .
[119] A. Ismail,et al. A review of the effects of emerging contaminants in wastewater and options for their removal , 2009 .
[120] Mira Petrovic,et al. Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor , 2006, Analytical and bioanalytical chemistry.
[121] L. Nghiem,et al. Removal of bisphenol A and diclofenac by a novel fungal membrane bioreactor operated under non- sterile conditions , 2013 .
[122] G. Feijoo,et al. Enzymatic membrane reactors for biodegradation of recalcitrant compounds. Application to dye decolourisation. , 2002, Journal of biotechnology.
[123] Ari Rabl,et al. Uncertainty of air pollution cost estimates: to what extent does it matter? , 2005, Environmental science & technology.
[124] Carlo Vandecasteele,et al. Removal of pollutants from surface water and groundwater by nanofiltration: overview of possible applications in the drinking water industry. , 2003, Environmental pollution.
[125] Stuart J. Khan,et al. Effect of mixed liquor pH on the removal of trace organic contaminants in a membrane bioreactor. , 2010, Bioresource technology.
[126] K. Kimura,et al. Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs) , 2005 .
[127] R. Moreira,et al. Removal of pharmaceutical compounds in membrane bioreactors (MBR) applying submerged membranes , 2010 .
[128] Samer Adham,et al. Are membrane bioreactors ready for widespread application? , 2005, Environmental science & technology.
[129] Yi‐nan Wu,et al. The removal of bisphenol A from aqueous solutions by MIL-53(Al) and mesostructured MIL-53(Al). , 2013, Journal of colloid and interface science.
[130] M. Yüksel,et al. Removal of bisphenol A (BPA) from water by various nanofiltration (NF) and reverse osmosis (RO) membranes. , 2013, Journal of hazardous materials.
[131] L. Mita,et al. Non-isothermal bioremediation of waters polluted by phenol and some of its derivatives by laccase covalently immobilized on polypropylene membranes , 2010 .
[132] Tzahi Y Cath,et al. Removal of trace organic chemicals and performance of a novel hybrid ultrafiltration-osmotic membrane bioreactor. , 2014, Environmental science & technology.
[133] S. Sakai,et al. Immobilization of Pseudomonas cepacia lipase onto electrospun polyacrylonitrile fibers through physical adsorption and application to transesterification in nonaqueous solvent , 2010, Biotechnology Letters.
[134] A. Seshasayee,et al. Genomic Analysis Reveals Distinct Concentration-Dependent Evolutionary Trajectories for Antibiotic Resistance in Escherichia coli , 2014, DNA research : an international journal for rapid publication of reports on genes and genomes.
[135] R. Tyagi,et al. Laccase-catalyzed conversion of natural and synthetic hormones from a municipal wastewater. , 2007, Water research.
[136] A. Schäfer,et al. Sorption of micropollutant estrone to a water treatment ion exchange resin. , 2010, Journal of environmental monitoring : JEM.
[137] Menachem Elimelech,et al. Influence of membrane surface properties on initial rate of colloidal fouling of reverse osmosis and nanofiltration membranes , 2001 .
[138] Long D. Nghiem,et al. Combining MBR and NF/RO membrane filtration for the removal of trace organics in indirect potable wa , 2010 .
[139] Santiago Esplugas,et al. Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents. , 2007, Journal of hazardous materials.
[140] Taro Urase,et al. Factors affecting removal of pharmaceutical substances and estrogens in membrane separation bioreactors , 2005 .
[141] A. Fane,et al. Adsorption of trace steroid estrogens to hydrophobic hollow fibre membranes , 2002 .
[142] Thorsten Reemtsma,et al. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. , 2005, Water research.
[143] C. Wisniewski,et al. MEMBRANE BIOREACTOR FOR TREATMENT OF PHARMACEUTICAL WASTEWATER CONTAINING ACETAMINOPHEN , 2010 .
[144] C. Dosoretz,et al. Influence of seasonal and operating conditions on the rejection of pharmaceutical active compounds by RO and NF membranes , 2011 .
[145] Yoshimasa Watanabe,et al. Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors. , 2007, Environmental science & technology.
[146] Mira Petrovic,et al. Pharmaceuticals in Drinking Water , 2012 .
[147] D. Barceló,et al. Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment. , 2008, Water research.
[148] Richard M. Lueptow,et al. Removal of organic contaminants by RO and NF membranes. , 2005, Journal of membrane science.
[149] G. Feijoo,et al. Oxidation of pharmaceutically active compounds by a ligninolytic fungal peroxidase , 2011, Biodegradation.
[150] E R Cornelissen,et al. Influence of electrostatic interactions on the rejection with NF and assessment of the removal efficiency during NF/GAC treatment of pharmaceutically active compounds in surface water. , 2007, Water research.